CPX-351 induces remission in newly diagnosed pediatric secondary myeloid malignancies.
Hu Y, Caldwell KJ, Onciu M, Federico SM, Salek M, Lewis S, Lei S, Zhang J, Nichols KE, Takemoto CM, Triplett BM, Farrar JE, Rubnitz JE, Ribeiro RC, Wlodarski MW.
Hu Y, et al. Among authors: federico sm.
Blood Adv. 2022 Jan 25;6(2):521-527. doi: 10.1182/bloodadvances.2021006139.
Blood Adv. 2022.
PMID: 34710216
Free PMC article.